DRAK2 regulates memory T cell responses following murine coronavirus infection

References

• Friedrich ML, Wen BG, Bain G, Kee BL, Katayama C, Murre C, Hedrick SM, Walsh CM. DRAK2, a lymphoid-enriched DAP kinase, regulates the TCR activation threshold during thymocyte selection. Int Immunol 2005; 17(11)1379–1390
   PubMed Web of Science ®Google Scholar
• McGargill MA, Wen BG, Walsh CM, Hedrick SM. A deficiency in Drak2 results in a T cell hypersensitivity and an unexpected resistance to autoimmunity. Immunity 2004; 21(6)781–791
   PubMed Web of Science ®Google Scholar
• Ramos SJ, Hardison JL, Stiles LN, Lane TE, Walsh CM. Anti-viral effector T cell responses and trafficking are not dependent upon DRAK2 signaling following viral infection of the central nervous system. Autoimmunity 2007; 40(1)54–65
   PubMed Web of Science ®Google Scholar
• Friedrich ML, Cui M, Hernandez JB, Weist BM, Andersen HM, Zhang X, Huang L, Walsh CM. Modulation of DRAK2 autophosphorylation by antigen receptor signaling in primary lymphocytes. J Biol Chem 2007; 282(7)4573–4584
   PubMed Web of Science ®Google Scholar
• Kogel D, Prehn JH, Scheidtmann KH. The DAP kinase family of pro-apoptotic proteins: Novel players in the apoptotic game. Bioessays 2001; 23(4)352–358
   PubMed Web of Science ®Google Scholar
• Holmes K, Lai M. Coronaviridae and their replication. Fields virology3rd ed., BN Fields, DM Knipe, PM Howley. Lippincott-Raven Publishers, Philadelphia 1996; Vol. 1: 1075–1094
   Google Scholar
• McIntosh K. Fields virology3rd ed., BN Fields, DM Knipe, PM Howley. Lippincott-Raven Publishers, Philadelphia 1996; Vol. 1: 401–430, Coronaviruses
   Google Scholar
• Perlman S, Buchmeier MJ. Effects of microbes on the immune system, MW Cunningham, RS Fujinami. Lippincott WIlliams and Wilkins, Philadelphia, PA 1999; 331–348
   Google Scholar
• Lane TE, Liu MT, Chen BP, Asensio VC, Samawi RM, Paoletti AD, Campbell IL, Kunkel SL, Fox HS, Buchmeier MJ. A central role for CD4(+) T cells and RANTES in virus-induced central nervous system inflammation and demyelination. J Virol 2000; 74(3)1415–1424
   PubMed Web of Science ®Google Scholar
• Marten NW, Stohlman SA, Bergmann CC. MHV infection of the CNS: Mechanisms of immune-mediated control. Viral Immunol 2001; 14(1)1–18
   PubMed Web of Science ®Google Scholar
• Pearce BD, Hobbs MV, McGraw TS, Buchmeier MJ. Cytokine induction during T-cell-mediated clearance of mouse hepatitis virus from neurons in vivo. J Virol 1994; 68(9)5483–5495
   PubMed Web of Science ®Google Scholar
• Williamson JS, Stohlman SA. Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+T cells. J Virol 1990; 64(9)4589–4592
   PubMed Web of Science ®Google Scholar
• Bergmann CC, Lane TE, Stohlman SA. Coronavirus infection of the central nervous system: Host-virus stand-off. Nat Rev Microbiol 2006; 4(2)121–132
   PubMed Web of Science ®Google Scholar
• Wang FI, Hinton DR, Gilmore W, Trousdale MD, Fleming JO. Sequential infection of glial cells by the murine hepatitis virus JHM strain (MHV-4) leads to a characteristic distribution of demyelination. Lab Invest 1992; 66(6)744–754
   PubMed Web of Science ®Google Scholar
• Stiles LN, Hardison JL, Schuamburg CS, Whitman LM, Lane TE. T cell anti-viral effector function is not dependent on CXCL10 following murine coronavirus infection. J Immunol 2006; 177(12)8372–8380
   PubMed Web of Science ®Google Scholar
• Xue S, Jaszewski A, Perlman S. Identification of a CD4+T cell epitope within the M protein of a neurotropic coronavirus. Virology 1995; 208(1)173–179
   PubMed Web of Science ®Google Scholar
• Fleming JO, Trousdale MD, el-Zaatari FA, Stohlman SA, Weiner LP. Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J Virol 1986; 58(3)869–875
   PubMed Web of Science ®Google Scholar
• Hirano N, Murakami T, Fujiwara K, Matsumoto M. Utility of mouse cell line DBT for propagation and assay of mouse hepatitis virus. Jpn J Exp Med 1978; 48(1)71–75
   PubMedGoogle Scholar
• Lane TE, Asensio VC, Yu N, Paoletti AD, Campbell IL, Buchmeier MJ. Dynamic regulation of alpha- and beta-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease. J Immunol 1998; 160(2)970–978
   PubMed Web of Science ®Google Scholar
• Kaech SM, Wherry EJ, Ahmed R. Effector and memory T-cell differentiation: Implications for vaccine development. Nat Rev Immunol 2002; 2(4)251–262
   PubMed Web of Science ®Google Scholar
• Hou S, Hyland L, Ryan KW, Portner A, Doherty PC. Virus-specific CD8+T-cell memory determined by clonal burst size. Nature 1994; 369(6482)652–654
   PubMed Web of Science ®Google Scholar
• Murali-Krishna K, Altman JD, Suresh M, Sourdive DJ, Zajac AJ, Miller JD, Slansky J, Ahmed R. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection. Immunity 1998; 8(2)177–187
   PubMed Web of Science ®Google Scholar
• Whitmire JK, Asano MS, Murali-Krishna K, Suresh M, Ahmed R. Long-term CD4 Th1 and Th2 memory following acute lymphocytic choriomeningitis virus infection. J Virol 1998; 72(10)8281–8288
   PubMed Web of Science ®Google Scholar
• Ahmed R, Gray D. Immunological memory and protective immunity: Understanding their relation. Science 1996; 272(5258)54–60
   PubMed Web of Science ®Google Scholar
• Kersh EN, Fitzpatrick DR, Murali-Krishna K, Shires J, Speck SH, Boss JM, Ahmed R. Rapid demethylation of the IFN-gamma gene occurs in memory but not naive CD8 T cells. J Immunol 2006; 176(7)4083–4093
   PubMed Web of Science ®Google Scholar
• Wilson CB, Makar KW, Shnyreva M, Fitzpatrick DR. DNA methylation and the expanding epigenetics of T cell lineage commitment. Semin Immunol 2005; 17(2)105–119
   PubMed Web of Science ®Google Scholar
• Manders PM, Hunter PJ, Telaranta AI, Carr JM, Marshall JL, Carrasco M, Murakami Y, Palmowski MJ, Cerundolo V, Kaech SM, et al. BCL6b mediates the enhanced magnitude of the secondary response of memory CD8+T lymphocytes. Proc Natl Acad Sci USA 2005; 102(21)7418–7425
   PubMed Web of Science ®Google Scholar
• Grayson JM, Murali-Krishna K, Altman JD, Ahmed R. Gene expression in antigen-specific CD8+T cells during viral infection. J Immunol 2001; 166(2)795–799
   PubMed Web of Science ®Google Scholar
• Bachmann MF, Barner M, Viola A, Kopf M. Distinct kinetics of cytokine production and cytolysis in effector and memory T cells after viral infection. Eur J Immunol 1999; 29(1)291–299
   PubMed Web of Science ®Google Scholar
• Veiga-Fernandes H, Walter U, Bourgeois C, McLean A, Rocha B. Response of naive and memory CD8+T cells to antigen stimulation in vivo. Nat Immunol 2000; 1(1)47–53
   PubMed Web of Science ®Google Scholar
• Mao J, Qiao X, Luo H, Wu J. Transgenic drak2 overexpression in mice leads to increased T cell apoptosis and compromised memory T cell development. J Biol Chem 2006; 281(18)12587–12595
   PubMed Web of Science ®Google Scholar
• Sanjo H, Kawai T, Akira S. DRAKs, novel serine/threonine kinases related to death-associated protein kinase that trigger apoptosis. J Biol Chem 1998; 273(44)29066–29071
   PubMed Web of Science ®Google Scholar
• Matsumoto M, Miyake Y, Nagita M, Inoue H, Shitakubo D, Takemoto K, Ohtsuka C, Murakami H, Nakamura N, Kanazawa H. A serine/threonine kinase which causes apoptosis-like cell death interacts with a calcineurin B-like protein capable of binding Na(+)/H(+) exchanger. J Biochem 2001; 130(2)217–225
   PubMed Web of Science ®Google Scholar